Making a
CHOICE for
W
ith so many changes and advances in the bleeding disorders community, it can leave many of us confused and uncertain about some of our treatment choices. You may have even asked yourself or your medical care team, "what products can I try?", or "which ones will even work for me?". Most healthcare professionals agree that inhibitor eradication/tolerization is still the preferred choice of care over bypassing agents, new or old. We've hand-picked two of our dearest friends (and their families) to share with you their experiences in inhibitor tolerization (IT.)
34
n
LIFELINES for HEALTH
n
Fall/Winter 2019
r o t i b i h In t n e m t Trea